| Host |
Rabbit |
| Klon |
ZR282 |
| Format |
Concentrate |
| Methode |
P |
| Vorbehandlung |
HIER |
| Positivkontrolle |
Epitheloid sarcoma |
| Verdünnung |
1:100 - 1:200 |
| Isotyp |
IgG |
| Verdünnung |
Full-length human BAF47 protein |
| Lokalisation |
Nucleus |
INI-1
|
Zeta Corporation |
ZR282 |
1 ml |
Concentrate |
CE/IVD |
Z2597RL |
-
|
| Host |
Rabbit |
| Klon |
ZR282 |
| Format |
Ready-to-use |
| Methode |
P |
| Vorbehandlung |
HIER |
| Positivkontrolle |
Epitheloid sarcoma |
| Verdünnung |
- |
| Isotyp |
IgG |
| Verdünnung |
Full-length human BAF47 protein |
| Lokalisation |
Nucleus |
INI-1
|
Zeta Corporation |
ZR282 |
7 ml |
Ready-to-use |
CE/IVD |
Z2597RP |
-
|
| Host |
Rabbit |
| Klon |
ZR282 |
| Format |
Concentrate |
| Methode |
P |
| Vorbehandlung |
HIER |
| Positivkontrolle |
Epitheloid sarcoma |
| Verdünnung |
1:100 - 1:200 |
| Isotyp |
IgG |
| Verdünnung |
Full-length human BAF47 protein |
| Lokalisation |
Nucleus |
INI-1
|
Zeta Corporation |
ZR282 |
0.5 ml |
Concentrate |
CE/IVD |
Z2597RS |
-
|
| Host |
Rabbit |
| Klon |
ZR282 |
| Format |
Concentrate |
| Methode |
P |
| Vorbehandlung |
HIER |
| Positivkontrolle |
Epitheloid sarcoma |
| Verdünnung |
1:100 - 1:200 |
| Isotyp |
IgG |
| Verdünnung |
Full-length human BAF47 protein |
| Lokalisation |
Nucleus |
INI-1
|
Zeta Corporation |
ZR282 |
0.1 ml |
Concentrate |
CE/IVD |
Z2597RT |
-
|
| Host |
Mouse |
| Klon |
A8 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Vorbehandlung |
Citrate or EDTA |
| Positivkontrolle |
Neuroendocrine tumor. |
| Verdünnung |
1:100 |
| Isotyp |
IgG1 /κ |
| Verdünnung |
Amino acid 81-125 at the N-terminus of human INSM |
| Lokalisation |
Nucleus |
INSM1
|
Zeta Corporation |
A8 |
1 ml |
Concentrate |
CE/IVD |
Z2330ML |
-
|
| Host |
Mouse |
| Klon |
A8 |
| Format |
Ready-to-use |
| Reaktivität |
- |
| Methode |
P |
| Vorbehandlung |
Citrate or EDTA |
| Positivkontrolle |
Neuroendocrine tumor. |
| Verdünnung |
- |
| Isotyp |
IgG1 /κ |
| Verdünnung |
Amino acid 81-125 at the N-terminus of human INSM |
| Lokalisation |
Nucleus |
INSM1
|
Zeta Corporation |
A8 |
7 ml |
Ready-to-use |
CE/IVD |
Z2330MP |
-
|
| Host |
Mouse |
| Klon |
A8 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Vorbehandlung |
Citrate or EDTA |
| Positivkontrolle |
Neuroendocrine tumor. |
| Verdünnung |
1:100 |
| Isotyp |
IgG1 /κ |
| Verdünnung |
Amino acid 81-125 at the N-terminus of human INSM |
| Lokalisation |
Nucleus |
INSM1
|
Zeta Corporation |
A8 |
0.5 ml |
Concentrate |
CE/IVD |
Z2330MS |
-
|
| Host |
Mouse |
| Klon |
A8 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Vorbehandlung |
Citrate or EDTA |
| Positivkontrolle |
Neuroendocrine tumor. |
| Verdünnung |
1:100 |
| Isotyp |
IgG1 /κ |
| Verdünnung |
Amino acid 81-125 at the N-terminus of human INSM |
| Lokalisation |
Nucleus |
INSM1
|
Zeta Corporation |
A8 |
0.1 ml |
Concentrate |
CE/IVD |
Z2330MT |
-
|
| Host |
Mouse |
| Klon |
A-8 |
| Format |
Concentrate |
| Methode |
P |
| Vorbehandlung |
EDTA |
| Positivkontrolle |
neuroendocrine tumor |
| Verdünnung |
1:50-1:200 |
| Isotyp |
Mouse IgG1 kappa |
| Verdünnung |
Amino acid 81-125 at the N-terminus of human INSM1 |
| Lokalisation |
Nuclear |
INSM1 (A-8)
|
Diagnostic Biosystems |
A-8 |
1 ml |
Concentrate |
CE/IVD |
MOB586 |
-
|
| Host |
Mouse |
| Klon |
A-8 |
| Format |
Concentrate |
| Methode |
P |
| Vorbehandlung |
EDTA |
| Positivkontrolle |
neuroendocrine tumor |
| Verdünnung |
1:50-1:200 |
| Isotyp |
Mouse IgG1 kappa |
| Verdünnung |
Amino acid 81-125 at the N-terminus of human INSM1 |
| Lokalisation |
Nuclear |
INSM1 (A-8)
|
Diagnostic Biosystems |
A-8 |
0.1 ml |
Concentrate |
CE/IVD |
MOB586-01 |
-
|
| Host |
Mouse |
| Klon |
A-8 |
| Format |
Concentrate |
| Methode |
P |
| Vorbehandlung |
EDTA |
| Positivkontrolle |
neuroendocrine tumor |
| Verdünnung |
1:50-1:200 |
| Isotyp |
Mouse IgG1 kappa |
| Verdünnung |
Amino acid 81-125 at the N-terminus of human INSM1 |
| Lokalisation |
Nuclear |
INSM1 (A-8)
|
Diagnostic Biosystems |
A-8 |
0.5 ml |
Concentrate |
CE/IVD |
MOB586-05 |
-
|
| Host |
Mouse |
| Klon |
A-8 |
| Format |
ready- |
| Methode |
P |
| Vorbehandlung |
EDTA |
| Positivkontrolle |
neuroendocrine tumor |
| Verdünnung |
--- |
| Isotyp |
Mouse IgG1 kappa |
| Verdünnung |
Amino acid 81-125 at the N-terminus of human INSM1 |
| Lokalisation |
Nuclear |
INSM1 (A-8)
|
Diagnostic Biosystems |
A-8 |
6 ml |
ready- |
CE/IVD |
PDM586 |
-
|
| Host |
Mouse |
| Klon |
2D11 |
| Format |
Purified |
| Methode |
P, EL |
| Isotyp |
Mouse IgG1 |
| Verdünnung |
Native |
Insulin
|
Zytomed Systems GmbH |
2D11 |
200 µg |
Purified |
RUO |
609-0755 |
-
|
| Host |
Mouse |
| Klon |
K36ac10 |
| Format |
Concentrate |
| Methode |
F, P |
| Positivkontrolle |
Pancreas |
| Verdünnung |
1:25 - 1:50 |
| Isotyp |
Mouse IgG1 |
| Lokalisation |
Cytoplasm |
Insulin
|
Diagnostic Biosystems |
K36ac10 |
1 ml |
Concentrate |
CE/IVD |
MOB234 |
-
|
| Host |
Mouse |
| Klon |
K36ac10 |
| Format |
Concentrate |
| Methode |
F, P |
| Positivkontrolle |
Pancreas |
| Verdünnung |
1:25 - 1:50 |
| Isotyp |
Mouse IgG1 |
| Lokalisation |
Cytoplasm |
Insulin
|
Diagnostic Biosystems |
K36ac10 |
0.1 ml |
Concentrate |
CE/IVD |
MOB234-01 |
-
|
| Host |
Mouse |
| Klon |
K36ac10 |
| Format |
Concentrate |
| Methode |
F, P |
| Positivkontrolle |
Pancreas |
| Verdünnung |
1:25 - 1:50 |
| Isotyp |
Mouse IgG1 |
| Lokalisation |
Cytoplasm |
Insulin
|
Diagnostic Biosystems |
K36ac10 |
0.5 ml |
Concentrate |
CE/IVD |
MOB234-05 |
-
|
| Host |
Mouse |
| Klon |
ZM83 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Normal pancreas. |
| Verdünnung |
1:100 - 1:200 |
| Isotyp |
IgG1 /κ/ IgG1 /κ |
| Verdünnung |
Recombinant INS protein |
| Lokalisation |
Cytoplasm |
Insulin
|
Zeta Corporation |
ZM83 |
1.0 ml |
Concentrate |
CE/IVD |
Z2525ML |
-
|
| Host |
Mouse |
| Klon |
ZM83 |
| Format |
Ready-to-use |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Normal pancreas. |
| Verdünnung |
- |
| Isotyp |
IgG1 /κ/ IgG1 /κ |
| Verdünnung |
Recombinant INS protein |
| Lokalisation |
Cytoplasm |
Insulin
|
Zeta Corporation |
ZM83 |
7 ml |
Ready-to-use |
CE/IVD |
Z2525MP |
-
|
| Host |
Mouse |
| Klon |
ZM83 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Normal pancreas. |
| Verdünnung |
1:100 - 1:200 |
| Isotyp |
IgG1 /κ/ IgG1 /κ |
| Verdünnung |
Recombinant INS protein |
| Lokalisation |
Cytoplasm |
Insulin
|
Zeta Corporation |
ZM83 |
0.5 ml |
Concentrate |
CE/IVD |
Z2525MS |
-
|
| Host |
Mouse |
| Klon |
ZM83 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Normal pancreas. |
| Verdünnung |
1:100 - 1:200 |
| Isotyp |
IgG1 /κ/ IgG1 /κ |
| Verdünnung |
Recombinant INS protein |
| Lokalisation |
Cytoplasm |
Insulin
|
Zeta Corporation |
ZM83 |
0.1 ml |
Concentrate |
CE/IVD |
Z2525MT |
-
|
| Host |
Mouse |
| Klon |
5B6/6 |
| Format |
Purified |
| Methode |
F, EL |
| Isotyp |
Mouse IgG1 |
| Verdünnung |
Native |
Insulin (Proinsulin)
|
Zytomed Systems GmbH |
5B6/6 |
200 µg |
Purified |
RUO |
609-0761 |
-
|
| Host |
Goat |
| Klon |
polyclonal |
| Format |
Lyophilised |
| Methode |
EL, WB |
| Isotyp |
Goat IgG |
| Verdünnung |
Recombinant mouse IGF-I |
Insulin-Like Growth Factor I (IGF1)
|
Zytomed Systems GmbH |
polyclonal |
100 µg |
Lyophilised |
RUO |
609-0769 |
-
|
| Host |
Mouse |
| Klon |
M23 |
| Format |
Purified |
| Methode |
F |
| Isotyp |
Mouse IgG1 |
Insulin-Like Growth Factor I (IGF1)
|
Zytomed Systems GmbH |
M23 |
100 µg |
Purified |
RUO |
609-0770 |
-
|
| Host |
Rabbit |
| Klon |
polyclonal |
| Format |
Purified |
| Methode |
EL, WB |
| Isotyp |
Rabbit IgG |
| Verdünnung |
Recombinant human IGF-I |
Insulin-Like Growth Factor I (IGF1)
|
Zytomed Systems GmbH |
polyclonal |
100 µg |
Purified |
RUO |
609-1047 |
-
|
| Host |
Mouse |
| Klon |
P1F6 |
| Format |
Purified |
| Methode |
F, IF, EL, FL, IP |
| Isotyp |
Mouse IgG1 |
| Verdünnung |
Human UCLA P3 cells (lung carcinoma) |
Integrin alphaV, beta5
|
Zytomed Systems GmbH |
P1F6 |
100 µg |
Purified |
RUO |
609-0778 |
-
|
| Host |
Mouse |
| Klon |
DB-1 |
| Format |
Purified |
| Methode |
F, EL |
| Isotyp |
Mouse IgG1 |
| Verdünnung |
Recombinant rat IFN gamma |
Interferon gamma (IFNg)
|
Zytomed Systems GmbH |
DB-1 |
100 µg |
Purified |
RUO |
609-0795 |
-
|
| Host |
Mouse |
| Klon |
49/20 |
| Format |
Purified |
| Methode |
WB, EL |
| Isotyp |
Mouse IgG1 |
| Verdünnung |
Human Interleukin-1 soluble receptor, type 1 expressed in insect cell line Sf |
Interleukin 1 Receptor Type I (IL-1R, CD121a)
|
Zytomed Systems GmbH |
49/20 |
100 µg |
Purified |
RUO |
609-0848 |
-
|
| Host |
Rabbit |
| Klon |
polyclonal |
| Format |
Lyophilised |
| Methode |
EL, WB |
| Isotyp |
Rabbit IgG |
| Verdünnung |
Recombinant mouse IL-4 |
Interleukin 4 (IL-4)
|
Zytomed Systems GmbH |
polyclonal |
100 µg |
Lyophilised |
RUO |
609-0951 |
-
|
| Host |
Rabbit |
| Klon |
polyclonal |
| Format |
Lyophilised |
| Methode |
IHC(P), EL, WB |
| Vorbehandlung |
HIER in Citrate Buffer |
| Verdünnung |
0.25 - 0.5 µg/ml |
| Isotyp |
Rabbit IgG |
| Verdünnung |
Recombinant human IL-6 |
Interleukin 6 (IL-6)
|
Zytomed Systems GmbH |
polyclonal |
100 µg |
Lyophilised |
RUO |
609-0985 |
-
|
| Host |
Rat |
| Klon |
JES3-12G8 |
| Format |
Purified |
| Methode |
EL, WB, FL, P |
| Isotyp |
Rat IgG2a |
| Verdünnung |
Human IL-10 expressed by COS cells |
Interleukin 10 (IL-10, CSIF)
|
Zytomed Systems GmbH |
JES3-12G8 |
500 µg |
Purified |
RUO |
609-0862 |
-
|
| Host |
Rabbit |
| Klon |
polyclonal |
| Format |
Lyophilised |
| Methode |
EL, WB |
| Isotyp |
Rabbit IgG |
| Verdünnung |
Recombinant human IL-17 |
Interleukin 17 (IL-17)
|
Zytomed Systems GmbH |
polyclonal |
100 µg |
Lyophilised |
RUO |
609-0903 |
-
|
| Host |
Rabbit |
| Klon |
SP105 |
| Format |
Concentrate |
| Methode |
P |
| Vorbehandlung |
Citrate |
| Positivkontrolle |
Tonsil |
| Verdünnung |
1:100 |
| Isotyp |
Rabbit IgG |
| Verdünnung |
Synthetic peptide near the internal region of human J-chain |
| Lokalisation |
Cytoplasm |
J-Chain
|
Zytomed Systems GmbH |
SP105 |
1 ml |
Concentrate |
RUO |
510-4054 |
-
|
| Host |
Mouse |
| Klon |
Mc19-9 |
| Format |
Purified |
| Methode |
F, EL, WB, IP |
| Isotyp |
Mouse IgG1 |
| Verdünnung |
Human J Chain |
J Chain
|
Zytomed Systems GmbH |
Mc19-9 |
200 µg |
Purified |
RUO |
610-0001 |
-
|
| Host |
Mouse+Rabbit |
| Klon |
L1C1+polyclonal |
| Format |
Ready-to-use |
| Methode |
P |
| Vorbehandlung |
Citrate |
| Positivkontrolle |
Tonsil, bone marrow |
| Verdünnung |
- |
| Isotyp |
Mouse IgG1+not determined |
| Lokalisation |
Cytoplasm |
Kappa + Lambda
|
Biocare Medical |
L1C1+polyclonal |
6 ml |
Ready-to-use |
CE/IVD |
API3159DSAA |
-
|
| Host |
Rabbit |
| Klon |
SP148 |
| Format |
Concentrate |
| Methode |
P, WB |
| Vorbehandlung |
EDTA |
| Positivkontrolle |
Tonsil |
| Verdünnung |
1:100 |
| Isotyp |
Rabbit IgG |
| Verdünnung |
Free kappa light chain from pooled human IgG kappa myeloma sera. |
| Lokalisation |
Cytoplasm |
Kappa Light Chain
|
Zytomed Systems GmbH |
SP148 |
0.5 ml |
Concentrate |
RUO |
511-4482 |
-
|
| Host |
Rabbit |
| Klon |
SP148 |
| Format |
Concentrate |
| Methode |
P, WB |
| Vorbehandlung |
EDTA |
| Positivkontrolle |
Tonsil |
| Verdünnung |
1:100 |
| Isotyp |
Rabbit IgG |
| Verdünnung |
Free kappa light chain from pooled human IgG kappa myeloma sera. |
| Lokalisation |
Cytoplasm |
Kappa Light Chain
|
Zytomed Systems GmbH |
SP148 |
1 ml |
Concentrate |
RUO |
511-4484 |
-
|
| Host |
Mouse |
| Klon |
L1C1 |
| Format |
Concentrate |
| Methode |
P |
| Vorbehandlung |
Reveal modified citrate buffer pH 6.0 |
| Positivkontrolle |
Tonsil or bone marrow |
| Verdünnung |
1:100 - 1:200 |
| Isotyp |
Mouse IgG1 |
| Lokalisation |
Cytoplasm |
Kappa Light Chain
|
Biocare Medical |
L1C1 |
0.1 ml |
Concentrate |
CE/IVD |
ACI3149A |
-
|
| Host |
Mouse |
| Klon |
L1C1 |
| Format |
Concentrate |
| Methode |
P |
| Vorbehandlung |
Reveal modified citrate buffer pH 6.0 |
| Positivkontrolle |
Tonsil or bone marrow |
| Verdünnung |
1:100 - 1:200 |
| Isotyp |
Mouse IgG1 |
| Lokalisation |
Cytoplasm |
Kappa Light Chain
|
Biocare Medical |
L1C1 |
1 ml |
Concentrate |
CE/IVD |
ACI3149C |
-
|
| Host |
Mouse |
| Klon |
L1C1 |
| Format |
Ready-to-use |
| Methode |
P |
| Vorbehandlung |
Reveal modified citrate buffer pH 6.0 |
| Positivkontrolle |
Tonsil or bone marrow |
| Verdünnung |
- |
| Isotyp |
Mouse IgG1 |
| Lokalisation |
Cytoplasm |
Kappa Light Chain
|
Biocare Medical |
L1C1 |
6 ml |
Ready-to-use |
CE/IVD |
API3149AA |
-
|
| Host |
Rabbit |
| Klon |
polyclonal |
| Format |
Ready-to-use |
| Methode |
F, P |
| Positivkontrolle |
Tonsil |
| Verdünnung |
- |
| Isotyp |
Rabbit IgG |
| Lokalisation |
Cytoplasm |
Kappa Light Chain
|
Diagnostic Biosystems |
polyclonal |
6 ml |
Ready-to-use |
CE/IVD |
PDR015 |
-
|
| Host |
Rabbit |
| Klon |
polyclonal |
| Format |
Concentrate |
| Methode |
F, P |
| Positivkontrolle |
Tonsil |
| Verdünnung |
1:100 - 1:500 |
| Isotyp |
Rabbit IgG |
| Lokalisation |
Cytoplasm |
Kappa Light Chain
|
Diagnostic Biosystems |
polyclonal |
1 ml |
Concentrate |
CE/IVD |
RP025 |
-
|
| Host |
Rabbit |
| Klon |
polyclonal |
| Format |
Concentrate |
| Methode |
F, P |
| Positivkontrolle |
Tonsil |
| Verdünnung |
1:100 - 1:500 |
| Isotyp |
Rabbit IgG |
| Lokalisation |
Cytoplasm |
Kappa Light Chain
|
Diagnostic Biosystems |
polyclonal |
0.1 ml |
Concentrate |
CE/IVD |
RP025-01 |
-
|
| Host |
Rabbit |
| Klon |
polyclonal |
| Format |
Concentrate |
| Methode |
F, P |
| Positivkontrolle |
Tonsil |
| Verdünnung |
1:100 - 1:500 |
| Isotyp |
Rabbit IgG |
| Lokalisation |
Cytoplasm |
Kappa Light Chain
|
Diagnostic Biosystems |
polyclonal |
0.5 ml |
Concentrate |
CE/IVD |
RP025-05 |
-
|
| Host |
Monospecific Mouse |
| Klon |
ZM81 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Vorbehandlung |
Citrate or EDTA |
| Positivkontrolle |
Tonsil or lymph node. |
| Verdünnung |
1:100 - 1:200 |
| Isotyp |
IgG1 /κ |
| Verdünnung |
Recombinant full-length human IGKC protein |
| Lokalisation |
Cytoplasm |
Kappa Light Chain
|
Zeta Corporation |
ZM81 |
1 ml |
Concentrate |
CE/IVD |
Z2532ML |
-
|
| Host |
Monospecific Mouse |
| Klon |
ZM81 |
| Format |
Ready-to-use |
| Reaktivität |
- |
| Methode |
P |
| Vorbehandlung |
Citrate or EDTA |
| Positivkontrolle |
Tonsil or lymph node. |
| Verdünnung |
- |
| Isotyp |
IgG1 /κ |
| Verdünnung |
Recombinant full-length human IGKC protein |
| Lokalisation |
Cytoplasm |
Kappa Light Chain
|
Zeta Corporation |
ZM81 |
7 ml |
Ready-to-use |
CE/IVD |
Z2532MP |
-
|
| Host |
Monospecific Mouse |
| Klon |
ZM81 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Vorbehandlung |
Citrate or EDTA |
| Positivkontrolle |
Tonsil or lymph node. |
| Verdünnung |
1:100 - 1:200 |
| Isotyp |
IgG1 /κ |
| Verdünnung |
Recombinant full-length human IGKC protein |
| Lokalisation |
Cytoplasm |
Kappa Light Chain
|
Zeta Corporation |
ZM81 |
0.5 ml |
Concentrate |
CE/IVD |
Z2532MS |
-
|
| Host |
Monospecific Mouse |
| Klon |
ZM81 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Vorbehandlung |
Citrate or EDTA |
| Positivkontrolle |
Tonsil or lymph node. |
| Verdünnung |
1:100 - 1:200 |
| Isotyp |
IgG1 /κ |
| Verdünnung |
Recombinant full-length human IGKC protein |
| Lokalisation |
Cytoplasm |
Kappa Light Chain
|
Zeta Corporation |
ZM81 |
0.1 ml |
Concentrate |
CE/IVD |
Z2532MT |
-
|
| Host |
Mouse |
| Klon |
KP-53 |
| Format |
Concentrate |
| Methode |
P |
| Vorbehandlung |
Citrate |
| Positivkontrolle |
Tonsil |
| Verdünnung |
1:25 - 1:50 |
| Isotyp |
IgG2b |
| Lokalisation |
Cytoplasm |
Kappa light chain (KP-53)
|
Diagnostic Biosystems |
KP-53 |
1 ml |
Concentrate |
CE/IVD |
MOB544 |
-
|
| Host |
Mouse |
| Klon |
KP-53 |
| Format |
Concentrate |
| Methode |
P |
| Vorbehandlung |
Citrate |
| Positivkontrolle |
Tonsil |
| Verdünnung |
1:25 - 1:50 |
| Isotyp |
IgG2b |
| Lokalisation |
Cytoplasm |
Kappa light chain (KP-53)
|
Diagnostic Biosystems |
KP-53 |
0.1 ml |
Concentrate |
CE/IVD |
MOB544-01 |
-
|
| Host |
Mouse |
| Klon |
KP-53 |
| Format |
Concentrate |
| Methode |
P |
| Vorbehandlung |
Citrate |
| Positivkontrolle |
Tonsil |
| Verdünnung |
1:25 - 1:50 |
| Isotyp |
IgG2b |
| Lokalisation |
Cytoplasm |
Kappa light chain (KP-53)
|
Diagnostic Biosystems |
KP-53 |
0.5 ml |
Concentrate |
CE/IVD |
MOB544-05 |
-
|